Send to

Choose Destination
J BUON. 2019 Jan-Feb;24(1):215-220.

Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer.

Author information

Department of Medical Oncology, Hainan Branch of Chinese PLA General Hospital, Sanya 572000, China.



To investigate the correlations of interleukin-26 (IL-26) with the diagnosis and pathological stage of gastric cancer by comparing the serum IL-26 levels in patients with different pathological stages of gastric cancer.


A total of 302 patients with gastric cancer hospitalized in Chinese PLA General Hospital from April 2015 to October 2017 were selected and divided into 4 groups according to the seventh edition of the staging guidance for gastric cancer of American Joint Committee on Cancer (AJCC), including stage I (n=75), stage II (n=73), stage III (n=125) and stage IV (n=29). Meanwhile, patients with benign stomach diseases admitted to the hospital during the same period were enrolled as controls (n=100). The differences in the levels of IL-26 and tumor markers between benign stomach diseases and gastric cancer and among stages were compared, and the correlations of IL-26 with the occurrence and different pathological stages of gastric cancer were analyzed.


The serum IL-26 level in the patients with gastric cancer was remarkably higher than that in benign stomach disease group [(267.14±20.39) vs. (172.12±13.38) pg/mL, p<0.05], which was similar to the change trends of tumor markers such as carbohydrate antigen (CA) 724. The serum IL-26 level in the gastric cancer tissues was gradually elevated with the increase in clinical stage of gastric cancer [stage I: (213.05±19.05) pg/mL, stage II: (244.98±24.14) pg/mL, stage III: (278.45±20.68) pg/mL and stage IV: (291.73±15.62) pg/mL; p<0.05]. The serum IL-26 level had positive correlations with gastric cancer (r=0.528, p<0.001). Logistic regression analysis indicated that serum IL-26 was still an independent risk factor for the occurrence of gastric cancer after age, gender, carcinoembryonic antigen (CEA), CA125 and other risk factors were adjusted [odds ratio (OR)=1.216, P=0.002].


The serum IL-26 level is closely correlated with gastric cancer and its clinicopathological stages, which is of important value for determination of the occurrence and development of the disease.


Supplemental Content

Loading ...
Support Center